Immunotherapy · 2019 · 16 citations · 26 references
Life SciencesDermatologyImmunologyHypersensitivityImmunoregulationImmunotherapyB Cell BiologyB Cell RegulationB-cell ResponsesRegulatory T CellsT Cell BiologyT Cell DifferentiationCytokine-mediated SuppressionInterleukin-10 Production By Regulatory T CellsPeripheral Blood Lymphocyte AnalysisPeripheral Regulatory T CellsRegulatory B Cell ResponsesSubcutaneous Allergen ImmunotherapyT Cell ImmunologyTr1 Cells
AIM: The aim of this study was to clarify whether there are more regulatory T (Treg) and regulatory B (Breg) cells, and higher levels of IL-10-related transcription factors in subcutaneous immunotherapy (SCIT)-treated pollinosis patients than in non-SCIT-treated patients. METHODS: Japanese cedar pollinosis patients undergoing SCIT had received treatment for at least 2.8 years. Peripheral blood mononuclear cells were used for flow cytometer analyses and mRNA measurement. RESULTS: The numbers of type 1 regulatory T (Tr1)-like cells and Breg cells, and expression of E4BP4 mRNA by peripheral blood mononuclear cells in SCIT-treated patients were higher than those in non-SCIT-treated patients. CONCLUSION: Tr1-like cells, Breg cells and E4BP4 may be involved in the effectiveness of SCIT.
26
Jung‐Hyun Park, Stanley Adoro, Terry I. Guinter et al. · Nature Immunology · 2010 · 5.8K citations · Full text
Shimon Sakaguchi, N Sakaguchi, M Asano et al. · The Journal of Immunology · 1995 · 5.5K citations
Life Sciences, Immunology, Pathology +17
WanJun Chen, Wenwen Jin, Neil J. Hardegen et al. · The Journal of Experimental Medicine · 2003 · 4.6K citations · Full text
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Stephen R. Durham, Samantha Walker, Eva‐Maria Varga et al. · New England Journal of Medicine · 1999 · 1.4K citations · Full text